Firstly, our xenograft models were used with cell line‐derived xenograft, patient‐derived xenograft (PDX) models of DLBCL would be more helpful in comprehending the role of NAT10 in DLBCL progression. The gene discussed is NAT10; the disease is diffuse large B-cell lymphoma.